The copd-6 identifies those at risk of COPD at the pre-symptomatic stage to allow early medical intervention and facilitate better clinical outcomes.
This pioneering device screens out those whose FEV1 is normal, and who therefore do not have COPD, without the risk of false COPD negatives, allowing spirometry resources to be focused on those most at risk.
"There are an estimated 2.8 million people in the UK who have undiagnosed or misdiagnosed COPD. Screening is essential if we are to find the missing millions and begin to treat them effectively. The copd-6 is really easy to use - it's no more difficult that a CO monitor in effect"
Stephen Foster,
Pharmacy Clinical Leader,
Health Professionals' Commissioning Network Lead